When examining the tumor types comprising the most patients (lung and breast cancers, each n=40), we found that the most frequent alterations reported were TP53 (32.5%), HER1/2 (27.5%), and PIK3CA (25%) in breast cancer cases (Figure 3A). Here, TP53 is linked to breast carcinoma.